Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • Ukraine signs amicable agreement with Gilead on hepatitis C drug

    Ukraine has signed an amicable agreement with U.S. Gilead Sciences, Inc. biopharmaceutical company on the Sovaldi medicine used to treat chronic hepatitis C infection in adults, acting Ukrainian Health Minister Ulana Suprun said at a press conference on Wednesday. The whole course of hepatitis C treatment with the use of Sovaldi in Ukraine will cost about $750.

    4 hours ago | Interfax Ukraine
  • Meet The Man Who Stopped Thousands Of People Becoming HIV-Positive

    “I knew I was doing something of substance, but it’s really overwhelming.” In an exclusive interview with BuzzFeed News, Greg Owen reveals the story behind Britain’s largest ever drop in HIV transmissions.

    26 February 2017 | BuzzFeed News
  • Egypt targets hepatitis C patients for medical tourism

    In mid 2016, Prime Pharma, a private Egyptian pharmaceutical company, launched Tour n’ Cure to revive therapeutic tourism in Egypt. The first target is hepatitis C patients from around the world. Countries targeted are Spain, Belgium, Italy, Netherlands and the UK.

    24 February 2017 | International Medical Tourism Journal
  • Messi visits Egypt to promote Hepatitis C treatment

    Supported by the Egyptian ministries of tourism and aviation, Prime Pharma started a campaign titled “Tour n’ Cure” to promote tourism treatment in Egypt, with Messi being chosen as ambassador for the campaign worldwide.

    22 February 2017 | Daily News Egypt
  • Deal reduces price of life-saving hepatitis C drugs for Canadians

    Tens of thousands of Canadian patients with mild versions of chronic hepatitis C could soon receive public funding for medications that cure the infection now that the provinces have sealed a deal with three pharmaceutical companies to reduce the cost of the ultra-expensive drugs.

    22 February 2017 | The Globe and Mail
  • How Mike Pence used Obamacare to halt Indiana's HIV outbreak

    Two years later, the vice president is helping lead the Republican effort to dismantle the program.

    21 February 2017 | Politico
  • Charities call for NHS to stop rationing critical care

    Theresa May has been urged by charity chiefs to stop the NHS rationing treatment for seriously ill patients and to find more money for their care in the budget next month. The charities from the Specialised Healthcare Alliance said this rationing is taking place without sufficient public scrutiny.

    21 February 2017 | The Guardian
  • An 18% Decline in HIV Incidence in the US Over Six Years is Not Enough

    David Holtgrave and Robert Bonacci: "At a time when some decision makers are considering possibly repealing and/or replacing the Affordable Care Act, which we know provided critical health insurance access for persons living with HIV and helped to avoid HIV transmission, we should instead be focusing as a nation on expanding critical HIV-related services and access to comprehensive care."

    16 February 2017 | Huffington Post
  • Commentary on U=U campaign - Follow Up on previous article 'On Fear, Infectiousness and Undetectability'

    Last week, GNP+ published a statement offering an alternative perspective on the messaging of campaigns on the uninfectiousness of people living with HIV who achieve viral suppression, including the U=U (Undetectable = Untransmittable) campaign. Following reactions from supporters of the campaign, GNP+ releases the following statement clarifying our position on this important issue.

    15 February 2017 | GNPPlus
  • Obamacare significantly expanded insurance for people with HIV

    The first national analysis of the impact of the Affordable Care Act on people with HIV showed significant increases in health insurance coverage among people infected with the virus that causes AIDS, according to a report released on Tuesday.

    15 February 2017 | Reuters
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.